COVID paused prevention efforts, which helped fuel the rise in new infections. Now federal funding cuts threaten to disrupt ...

President Donald Trump's budget proposal for fiscal year 2026 requests significant reductions to HIV prevention and ...

Sonali Kulkarni, M.D., M.P.H., Medical Director in the Division of HIV and STD Programs at the Los Angeles County Department ...

Increased PrEP usage is linked to decreased HIV diagnosis rates, with a notable decline from 13.0 to 10.6 per 100,000 over a decade. State-level PrEP coverage significantly impacts HIV diagnosis rates ...

The COVID-19 pandemic paused many HIV prevention efforts, which helped fuel last year's rise in new infections. President ...

WASHINGTON D.C., DC — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.… ...

The US Food and Drug Administration on June 18, 2025 approved Gilead Sciences’ twice-yearly injection to prevent HIV — a move the company hailed as a major breakthrough in the fight against ...

The Food and Drug Administration on Wednesday approved a powerful new prevention drug for HIV called Yeztugo that promises to keep most people virus-free with two shots a year. The drug Made by ...

Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide.